Press Releases :: VolitionRx Ltd (VNRX)

May 19, 2020 • 4:01 PM EDT VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

May 13, 2020 • 5:00 PM EDT VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting

May 7, 2020 • 4:10 PM EDT VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update

May 5, 2020 • 8:30 AM EDT VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update

Apr 29, 2020 • 8:30 AM EDT Volition's Nu.Q™ Vet Assay Detects Two Common Canine Cancers

Apr 23, 2020 • 8:30 AM EDT Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies

Mar 10, 2020 • 8:45 AM EDT VolitionRx Limited Releases Annual Corporate Brochure and Video

Mar 3, 2020 • 8:30 AM EST VolitionRx Limited to Present at Conferences in March 2020

Feb 20, 2020 • 4:10 PM EST VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

Feb 18, 2020 • 4:10 PM EST VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update